Share ownership Sino Biopharmaceutical Limited

1177

KYG8167W1380

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:39:02 15/06/2026 pm IST			5-day change	1st Jan Change
4.780 ^HKD	+1.70%		+5.52%	-22.65%

06:53am	Sino Biopharmaceutical Plans HK$2 Billion Stock Buyback	MT
30/05	Sino Biopharmaceutical Limited Announces Approval For Marketing of Naldemedine For Opioid-Induced Constipation In Adults	CI

Share class: Sino Biopharmaceutical Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,57,36,42,123	9,61,36,92,595 ( 49.12 %)	86,86,24,893 ( 4.438 %)	49.12 %

Major shareholders: Sino Biopharmaceutical Limited

Name	Stocks	%	Valuation
S Y Tse 21.63 %	4,05,50,00,000	21.63 %	2 582 M $
Cheung Ling Cheng 15.86 %	2,97,36,78,124	15.86 %	1 893 M $
Ping Tse 9.038 %	1,69,42,70,241	9.038 %	1 079 M $
Hsin Tse 1.923 %	36,05,57,270	1.923 %	230 M $
Yinhua Fund Management Co., Ltd. 0.7352 %	13,78,19,000	0.7352 %	88 M $
ICBC UBS Asset Management Co. Ltd. 0.7174 %	13,44,86,675	0.7174 %	86 M $
China Asset Management Co., Ltd. 0.4083 %	7,65,39,500	0.4083 %	49 M $
Goldman Sachs Asset Management International 0.2206 %	4,13,60,200	0.2206 %	26 M $
Fullgoal Fund Management Co., Ltd. 0.2137 %	4,00,58,468	0.2137 %	26 M $
Invesco Great Wall Fund Management Co. Ltd. 0.1876 %	3,51,68,000	0.1876 %	22 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	48.5%
Institutional	4.19%
Unknown	47.31%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	48.51%
China	3.02%
United Kingdom	0.38%
Hong Kong	0.19%
United States	0.16%
Luxembourg	0.11%
Denmark	0.05%
Ireland	0.05%
Canada	0.04%
Slovenia	0.03%
Switzerland	0.02%
Austria	0.02%
Netherlands	0.02%
Singapore	0.02%
Malaysia	0.01%
New Zealand	0.01%
Finland	0.01%
Japan	0.01%
Brazil	0.01%

Based on 1000 largest holdings

Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.

Employees

21,435

Sector

Pharmaceuticals

Calendar

24/06 - Ex-dividend date - 0.05 HKD

More about the company